Treating Inappropriate Laughing and/or Crying in MS
Medication can play a crucial role in alleviating multiple sclerosis symptoms — including pseudobulbar affect, or inappropriate laughing and/or crying. When combined with other vital elements of comprehensive MS care, MS symptom medication can help you manage this symptom and improve your overall quality of life.
The medication on this page is approved by the U.S. Food and Drug Administration (FDA) to treat emotional changes in MS, specifically inappropriate laughing and/or crying. Discuss your MS treatment plan with your healthcare provider.
FDA-Approved Medication for Pseudobulbar Affect in MS
Nuedexta®
Brand Names: Nuedexta (U.S.)
Chemical Name: dextromethorphan hydrobromide + quinidine sulfate
Generic Available: No
Description: Nuedexta is a combination of dextromethorphan hydrobromide and quinidine sulfate. It is approved by the FDA to treat pseudobulbar affect (uncontrolled episodes of crying and/or laughing that are disconnected from or out of proportion to what the person is feeling at the time) in people with MS and other neurological diseases.
Read the
Nuedexta prescribing information.
Read about the
Nuedexta patient support program or call 855-468-3339.